- Home
- Publications
- Publication Search
- Publication Details
Title
Applications of CYP450 Testing in the Clinical Setting
Authors
Keywords
Tamoxifen, Clopidogrel, Tramadol, Carvedilol, Oxycodone
Journal
Molecular Diagnosis & Therapy
Volume 17, Issue 3, Pages 165-184
Publisher
Springer Nature
Online
2013-04-15
DOI
10.1007/s40291-013-0028-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serotonin syndrome following drug–drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient
- (2012) Kuntheavy I. Lorenzini et al. AIDS
- Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With Clopidogrel
- (2012) Jae-Sik Jang et al. AMERICAN JOURNAL OF CARDIOLOGY
- CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8
- (2012) M. P. Goetz et al. CLINICAL CANCER RESEARCH
- Comparative Pharmacokinetics and Pharmacodynamics of Platelet Adenosine Diphosphate Receptor Antagonists and their Clinical Implications
- (2012) Christopher N. Floyd et al. CLINICAL PHARMACOKINETICS
- Oral Flurbiprofen Metabolic Ratio Assessment Using a Single-Point Dried Blood Spot
- (2012) Y Daali et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Individualization of Tamoxifen Treatment for Breast Carcinoma
- (2012) L Binkhorst et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clopidogrel: A Case for Indication-Specific Pharmacogenetics
- (2012) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cytochrome P450 variations in different ethnic populations
- (2012) Joseph McGraw et al. Expert Opinion on Drug Metabolism & Toxicology
- Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory
- (2012) Charles M. Strom et al. GENETICS IN MEDICINE
- Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters
- (2012) Hiltrud Brauch et al. JOURNAL OF CLINICAL ONCOLOGY
- CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients
- (2012) James M. Rae et al. JNCI-Journal of the National Cancer Institute
- CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial
- (2012) Meredith M. Regan et al. JNCI-Journal of the National Cancer Institute
- Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users
- (2012) T. I. VERHOEF et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- More Codeine Fatalities After Tonsillectomy in North American Children
- (2012) L. E. Kelly et al. PEDIATRICS
- Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes
- (2012) S Martis et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects
- (2012) S C Sim et al. PHARMACOGENOMICS JOURNAL
- Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications
- (2011) Julien Déglon et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients
- (2011) Kazuma Kiyotani et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients
- (2011) Joanne S. L. Lim et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Increasing Tamoxifen Dose in Breast Cancer Patients Based on CYP2D6 Genotypes and Endoxifen Levels: Effect on Active Metabolite Isomers and the Antiestrogenic Activity Score
- (2011) M F Barginear et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma
- (2011) T E Mürdter et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
- (2011) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
- (2011) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Novel advances in cytochrome P450 research
- (2011) Deepika Singh et al. DRUG DISCOVERY TODAY
- Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting
- (2011) Osman Gökalp et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
- (2011) William J. Irvin et al. JOURNAL OF CLINICAL ONCOLOGY
- PharmGKB summary
- (2011) Stuart A. Scott et al. Pharmacogenetics and Genomics
- Update on the pharmacogenomics of proton pump inhibitors
- (2011) Krisztina Hagymási et al. PHARMACOGENOMICS
- Effects of Paroxetine on the Pharmacokinetics and Pharmacodynamics of Immediate-Release and Extended-Release Metoprolol
- (2011) Robert B Parker et al. PHARMACOTHERAPY
- The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone
- (2010) CF Samer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety
- (2010) CF Samer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Drug-Drug Interaction Profiles of Proton Pump Inhibitors
- (2010) Ryuichi Ogawa et al. CLINICAL PHARMACOKINETICS
- CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin
- (2010) N Carbonell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients
- (2010) Ramasamy Kesavan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation
- (2010) Andrew N. Freedman et al. JNCI-Journal of the National Cancer Institute
- CYP2C19 variation and citalopram response
- (2010) David A. Mrazek et al. Pharmacogenetics and Genomics
- Personalized therapy in pain management: where do we stand?
- (2010) Ulrike M Stamer et al. PHARMACOGENOMICS
- Dried Blood Spots as a Sample Collection Technique for the Determination of Pharmacokinetics in Clinical Studies: Considerations for the Validation of a Quantitative Bioanalytical Method
- (2009) Neil Spooner et al. ANALYTICAL CHEMISTRY
- The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users
- (2009) Monique J. Bijl et al. BREAST CANCER RESEARCH AND TREATMENT
- Proton Pump Inhibitors
- (2009) Kwong Ming Fock et al. CLINICAL PHARMACOKINETICS
- Polymorphism of human cytochrome P450 enzymes and its clinical impact
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of Tramadol
- (2009) Julia Kirchheiner et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment
- (2008) Y. Xu et al. ANNALS OF ONCOLOGY
- Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy
- (2008) Kazuma Kiyotani et al. CANCER SCIENCE
- Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study
- (2008) P Madadi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities
- (2008) José de Leon et al. CLINICS IN LABORATORY MEDICINE
- Prevalence, Clinical Features and Avoidability of Adverse Drug Reactions as Cause of Admission to??a??Geriatric Unit
- (2008) Marilisa Franceschi et al. DRUG SAFETY
- Proton pump inhibitors: an update of their clinical use and pharmacokinetics
- (2008) Shaojun Shi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction
- (2008) Ksenia Goryachkina et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics of analgesics: toward the individualization of prescription
- (2008) Victoria Rollason et al. PHARMACOGENOMICS
- Effects ofCYP2C9andVKORC1on INR variations and dose requirements during initial phase of anticoagulant therapy
- (2008) Marta Spreafico et al. PHARMACOGENOMICS
- The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction
- (2008) M C Rebsamen et al. PHARMACOGENOMICS JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search